首页> 外文期刊>Journal of drug targeting >The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats.
【24h】

The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats.

机译:经大鼠鼻内施用MPEG-PLA纳米颗粒后的脑靶向效率。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to encapsulate nimodipine (NM) within methoxy poly(ethylene glycol)-poly(lactic acid) (MPEG-PLA) nanoparticles and to investigate its brain targeting efficiency following intranasal administration. NM-loaded nanoparticles, prepared through an emulsion/solvent evaporation technique, were characterized in terms of size, zeta potential, NM loading and in vitro release. The nanoparticles were administered intranasally to rats, and the concentrations of NM in blood, cerebrospinal fluid (CSF) and brain tissues were monitored. The contribution of the olfactory pathway to the uptake of NM in the brain was determined by calculating the brain/plasma concentration ratios and "brain drug direct transport percentage (DTP)" following intranasal administration of the nanoparticles and the solution formulation. The results showed that MPEG-PLA nanoparticles had a mean particle size of 76.5 +/- 7.4 nm, a negative surface charge and a 5.2% NM loading. In vitro release was moderate under sink conditions. The intranasal administration of nanoparticles resulted in a low but constant NM level in plasma. The ratio of AUC values of the nanoparticles to the solution was 1.56 in CSF. The olfactory bulb/plasma and CSF/plasma concentration ratios were significantly higher (P < 0.05) after application of nanoparticles than those of the nasal solution, except the ratio in olfactory bulb at 5 min. Furthermore, nasally administered nanoparticles yielded 1.6-3.3-fold greater DTP values in CSF, olfactory bulb and other brain tissues compared to nasal solution. Thus, MPEG-PLA nanoparticles demonstrated its potential on improving the efficacy of the direct nose-brain transport for drugs.
机译:这项研究的目的是将尼莫地平(NM)封装在甲氧基聚(乙二醇)-聚(乳酸)(MPEG-PLA)纳米颗粒中,并研究鼻内给药后对大脑的靶向作用。通过乳液/溶剂蒸发技术制备的NM负载纳米颗粒的尺寸,ζ电位,NM负载和体外释放均经过表征。将纳米颗粒鼻内给药于大鼠,并监测血液,脑脊液(CSF)和脑组织中NM的浓度。通过计算鼻内施用纳米颗粒和溶液制剂后的脑/血浆浓度比和“脑药物直接转运百分比(DTP)”来确定嗅觉途径对脑中NM摄取的贡献。结果表明,MPEG-PLA纳米颗粒的平均粒径为76.5 +/- 7.4 nm,表面负电荷,NM负载为5.2%。在水槽下体外释放适度。鼻内给药纳米颗粒导致血浆中较低但恒定的NM水平。纳米颗粒与溶液的AUC值之比在CSF中为1.56。应用纳米颗粒后,嗅球/血浆和脑脊液/血浆的浓度比显着高于鼻溶液(P <0.05),除了在5分钟时嗅球中的比率。此外,与鼻溶液相比,经鼻给药的纳米颗粒在CSF,嗅球和其他脑组织中产生的DTP值高1.6-3.3倍。因此,MPEG-PLA纳米颗粒展示了其在改善药物直接鼻脑运输功效方面的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号